To the best of our knowledge, SHIDC-B-Ki-67 is the first benchmark introducing IHC marked breast cancer specimens that has cell annotations in three different classes of immunopositive, immuno negative, and tumor infiltrating lymphocytes. This evidence concerns the gene MKI67 and breast cancer.